4.5 Article

microRNA-143-3p contributes to inflammatory reactions by targetingFOSL2in PBMCs from patients with autoimmune diabetes mellitus

Journal

ACTA DIABETOLOGICA
Volume 58, Issue 1, Pages 63-72

Publisher

SPRINGER-VERLAG ITALIA SRL
DOI: 10.1007/s00592-020-01591-9

Keywords

Autoimmune diabetes mellitus; PBMCs; miR-143-3p; FOSL2; Cytokines

Funding

  1. National Key R&D Program of China [2018YFC1315603]
  2. Science and Technology Major Project of Hunan Province [2017SK1020]
  3. National Natural Science Foundation of China [81820108007]

Ask authors/readers for more resources

In this study, miR-143-3p expression was found to be upregulated in ADM patients, with FOSL2 identified as its target gene. By modulating FOSL2, miR-143-3p may participate in the pathogenesis of ADM by regulating the inflammatory reaction.
Aim Autoimmune diabetes mellitus (defined as ADM) comprises classical type 1 diabetes mellitus (T1DM) and latent autoimmune diabetes in adults (LADA). In this study, microRNAs (miRNAs) expression profiles and functions in peripheral blood mononuclear cells (PBMCs) of ADM patients were mapped and used to explore epigenetic regulation of the pathogenesis of ADM. Methods PBMCs samples from T1DM patients, LADA patients, and type 2 diabetes mellitus (T2DM) patients, as well as age- and sex-matched healthy controls for T1DM and T2DM, respectively, were collected and were sequenced to screen the miRNAs expression profiles. The target genes were verified by dual-luciferase reporter assay. Silencing or overexpressing of the differentially expressed miRNAs, or simultaneously silencing the miRNAs and it's target gene, and then levels of the mRNAs, protein and cytokines were detected. Results miR-143-3p expression was upregulated in ADM patients. The target gene of miR-143-3p was identified as Fos-related antigen 2 (FOSL2). Transfection of a miR-143-3p inhibitor into PBMCs upregulatedFOSL2expression, resulting in a downregulated expression of the IL-2, TNF-alpha, and IFN-gamma, and an upregulated expression of IL-6. Transfection of a miR-143-3p mimic into PBMCs downregulatedFOSL2expression, leading to an upregulation of IL-2 and TNF-alpha expression and a downregulation of IL-6 expression. When silencingFOSL2while inhibiting miR-143-3p in PBMCs, there was no significant change in expression of the FOSL2 mRNA, protein and cytokines. Conclusion The expression of miR-143-3p in PBMCs from ADM patients is upregulated. miR-143-3p could function in the pathogenesis of ADM by modulating the inflammatory reaction throughFOSL2.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available